Sign for Notice Everyday    Sign Up| Sign In| Link|

Our Sponsors

Receive Latest News

Share Us

Adoptive Cell Transfer Congress

View: 355

Website | Edit Freely

Category Oncology; CAR-T; immuno-oncology; Adoptive Cell Transfer; ACT

Deadline: October 04, 2019 | Date: October 10, 2019-October 11, 2019

Venue/Country: London Heathrow Marriott Hotel, U.K.

Updated: 2018-12-18 23:19:34 (GMT+9)

Call For Papers - CFP


Part of the Research & Technology Series, this conference explores the exciting field of cell and gene therapy in immuno-oncology.

The modification of patient and donor t cells offers a potent weapon in the fight against cancer, and with the recent regulatory approval, several CAR-T Cell products in the US and Europe these therapies stand poised to enter the clinic.

This conference offers experts working in the pharmaceutical industry and academia the opportunity to explore the latest developments in CAR T cell therapies, and the up-and-coming field of T Cell Receptor therapies. Presentations will explore design and development strategies for the modification of patient and donor t cells, receptor engineering and target selection, and will review the advantages and challenges remaining in their use.

Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.